The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, multicenter, single-arm study of eribulin mesilate as first-line therapy for HER2-negative locally advanced or metastatic breast cancer.
 
Seika Tei
No Relationships to Disclose
 
Tsutomu Takashima
Honoraria - Eisai
 
Shinichiro Kashiwagi
No Relationships to Disclose
 
Hidemi Kawajiri
No Relationships to Disclose
 
Shinya Tokunaga
No Relationships to Disclose
 
Shigehiko Nishimura
No Relationships to Disclose
 
Shigehito Yamagata
No Relationships to Disclose
 
Takeo Nishimori
No Relationships to Disclose
 
Yoko Mizuyama
No Relationships to Disclose
 
Tsuyoshi Sunami
No Relationships to Disclose
 
Kenji Tezuka
No Relationships to Disclose
 
Satoru Noda
No Relationships to Disclose
 
Katsumi Ikeda
No Relationships to Disclose
 
Yoshinari Ogawa
No Relationships to Disclose
 
Naoyoshi Onoda
No Relationships to Disclose
 
Tetsuro Ishikawa
No Relationships to Disclose
 
Shinzoh Kudoh
No Relationships to Disclose
 
Minoru Takada
No Relationships to Disclose
 
Kosei Hirakawa
No Relationships to Disclose